Biogen (BIIB) News Today $124.14 +5.97 (+5.05%) As of 10:15 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock BIIB Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period Rep. Robert Bresnahan, Jr. Sells Biogen Inc. (NASDAQ:BIIB) StockRepresentative Robert Bresnahan, Jr. (R-Pennsylvania) recently sold shares of Biogen Inc. (NASDAQ:BIIB). In a filing disclosed on May 08th, the Representative disclosed that they had sold between $1,001 and $15,000 in Biogen stock on April 8th. The trade occurred in the Representative's "JP MORGANMay 12 at 8:06 AM | marketbeat.comBiogen Q1 Earnings TranscriptMay 12 at 7:21 AM | marketbeat.comDeutsche Bank AG Buys 455,285 Shares of Biogen Inc. (NASDAQ:BIIB)Deutsche Bank AG grew its stake in shares of Biogen Inc. (NASDAQ:BIIB - Free Report) by 63.7% in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 1,169,570 shares of the biotechnology company's stock after acquiring an additional 455,285 shareMay 12 at 5:27 AM | marketbeat.comBiogen Inc. (NASDAQ:BIIB) Shares Sold by DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am MainDZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main decreased its position in shares of Biogen Inc. (NASDAQ:BIIB - Free Report) by 4.2% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 72,818 shares of tMay 12 at 5:25 AM | marketbeat.comJeito Capital Strengthens Leadership for Next Chapter of Growth: Mehdi Ainouche Promoted to Partner, Julien Elric to Senior PrincipalMay 12 at 1:00 AM | globenewswire.comBiogen (NASDAQ:BIIB) and Big Cypress Acquisition (OTCMKTS:BCYP) Head-To-Head AnalysisMay 11 at 2:08 AM | americanbankingnews.comBiogen Inc. (NASDAQ:BIIB) Shares Sold by Bokf NaBokf Na lowered its position in Biogen Inc. (NASDAQ:BIIB - Free Report) by 13.9% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 20,852 shares of the biotechnology company's stock after selling 3,357 shares during the quartMay 10 at 5:39 AM | marketbeat.comBrevan Howard Capital Management LP Purchases 6,064 Shares of Biogen Inc. (NASDAQ:BIIB)Brevan Howard Capital Management LP increased its position in shares of Biogen Inc. (NASDAQ:BIIB - Free Report) by 564.6% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 7,138 shares of the biotechnology company's stoMay 10 at 5:31 AM | marketbeat.comBiogen (NASDAQ:BIIB) Given New $169.00 Price Target at MizuhoMizuho dropped their target price on shares of Biogen from $207.00 to $169.00 and set an "outperform" rating on the stock in a report on Wednesday.May 9 at 9:37 AM | marketbeat.comBiogen Inc. (NASDAQ:BIIB) Shares Sold by Comerica BankComerica Bank lowered its holdings in shares of Biogen Inc. (NASDAQ:BIIB - Free Report) by 14.5% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 33,696 shares of the biotechnology company's stock afMay 8, 2025 | marketbeat.comStifel Financial Corp Reduces Holdings in Biogen Inc. (NASDAQ:BIIB)Stifel Financial Corp trimmed its holdings in shares of Biogen Inc. (NASDAQ:BIIB - Free Report) by 73.2% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 12,756 shares of the biotechnology company's stock after selling 34,7May 8, 2025 | marketbeat.comAfter big acquisition, Biogen looks to set up West Coast hub in South San FranciscoMay 7, 2025 | bizjournals.comBiogen (NASDAQ:BIIB) Given New $175.00 Price Target at JPMorgan Chase & Co.JPMorgan Chase & Co. decreased their price target on Biogen from $185.00 to $175.00 and set a "neutral" rating on the stock in a report on Monday.May 7, 2025 | marketbeat.comBiogen (BIIB) Price Target Lowered by Mizuho Despite Outperform Rating | BIIB Stock NewsMay 7, 2025 | gurufocus.comBiogen Inc. (NASDAQ:BIIB) Shares Acquired by Brown Advisory Inc.Brown Advisory Inc. grew its stake in Biogen Inc. (NASDAQ:BIIB - Free Report) by 4.3% during the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 347,566 shares of the biotechnology company's stock after acquiring an additional 14,339 shares during the period. BrMay 7, 2025 | marketbeat.comAxa S.A. Acquires 103,677 Shares of Biogen Inc. (NASDAQ:BIIB)Axa S.A. grew its holdings in shares of Biogen Inc. (NASDAQ:BIIB - Free Report) by 178.9% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 161,636 shares of the biotechnology company's stock after acquiriMay 7, 2025 | marketbeat.comWedbush Has Optimistic Outlook of Biogen Q4 EarningsMay 6, 2025 | americanbankingnews.comFY2025 Earnings Forecast for Biogen Issued By William BlairMay 6, 2025 | americanbankingnews.comJPMorgan Chase & Co. Issues Pessimistic Forecast for Biogen (NASDAQ:BIIB) Stock PriceMay 6, 2025 | americanbankingnews.comWedbush Issues Optimistic Forecast for Biogen EarningsBiogen Inc. (NASDAQ:BIIB - Free Report) - Equities researchers at Wedbush upped their Q4 2025 earnings per share estimates for shares of Biogen in a research note issued on Friday, May 2nd. Wedbush analyst L. Chico now expects that the biotechnology company will earn $3.95 per share for the quartMay 6, 2025 | marketbeat.comFY2025 Earnings Estimate for Biogen Issued By William BlairBiogen Inc. (NASDAQ:BIIB - Free Report) - Analysts at William Blair boosted their FY2025 earnings per share estimates for shares of Biogen in a research report issued to clients and investors on Thursday, May 1st. William Blair analyst M. Minter now forecasts that the biotechnology company will pMay 6, 2025 | marketbeat.comLeerink Partnrs Predicts Biogen's Q3 Earnings (NASDAQ:BIIB)Biogen Inc. (NASDAQ:BIIB - Free Report) - Investment analysts at Leerink Partnrs upped their Q3 2025 earnings per share estimates for shares of Biogen in a research report issued to clients and investors on Thursday, May 1st. Leerink Partnrs analyst M. Goodman now expects that the biotechnology cMay 6, 2025 | marketbeat.comBiogen’s Hold Rating: Balancing New Drug Growth with Declining MS Franchise and Safety ConcernsMay 5, 2025 | tipranks.comBiogen’s International Growth and Promising Pipeline Drive Buy RatingMay 5, 2025 | tipranks.comBiogen (NASDAQ:BIIB) Receives Hold Rating from Needham & Company LLCMay 5, 2025 | americanbankingnews.comBiogen (NASDAQ:BIIB) Price Target Lowered to $220.00 at Canaccord Genuity GroupMay 5, 2025 | americanbankingnews.comLeerink Partnrs Estimates Biogen's Q3 Earnings (NASDAQ:BIIB)May 5, 2025 | americanbankingnews.comBiogen Inc. (NASDAQ:BIIB) Receives Average Rating of "Hold" from AnalystsBiogen Inc. (NASDAQ:BIIB - Get Free Report) has been given an average recommendation of "Hold" by the thirty-two ratings firms that are covering the stock, MarketBeat reports. Twenty investment analysts have rated the stock with a hold rating and twelve have issued a buy rating on the company. ThMay 5, 2025 | marketbeat.comBiogen (NASDAQ:BIIB) Price Target Lowered to $187.00 at HC WainwrightHC Wainwright lowered their price objective on shares of Biogen from $241.00 to $187.00 and set a "buy" rating for the company in a research report on Friday.May 4, 2025 | marketbeat.comBiogen (NASDAQ:BIIB) Announces Quarterly Earnings Results, Misses Expectations By $0.24 EPSBiogen (NASDAQ:BIIB - Get Free Report) released its quarterly earnings results on Thursday. The biotechnology company reported $3.02 earnings per share (EPS) for the quarter, missing the consensus estimate of $3.26 by ($0.24). Biogen had a return on equity of 14.98% and a net margin of 16.87%. The firm had revenue of $2.43 billion for the quarter, compared to the consensus estimate of $2.25 billion. During the same quarter in the previous year, the business posted $3.67 EPS. The firm's revenue for the quarter was up 6.2% compared to the same quarter last year.May 4, 2025 | marketbeat.comRobert W. Baird Cuts Biogen (NASDAQ:BIIB) Price Target to $255.00Robert W. Baird reduced their price objective on Biogen from $300.00 to $255.00 and set an "outperform" rating for the company in a research note on Friday.May 4, 2025 | marketbeat.comBiogen's (BIIB) Hold Rating Reaffirmed at Needham & Company LLCNeedham & Company LLC reissued a "hold" rating on shares of Biogen in a research report on Friday.May 4, 2025 | marketbeat.comBiogen Inc. (NASDAQ:BIIB) Shares Purchased by Northern Trust CorpNorthern Trust Corp raised its position in Biogen Inc. (NASDAQ:BIIB - Free Report) by 14.6% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,550,130 shares of the biotechnology company's stock after aMay 4, 2025 | marketbeat.comBiogen Inc. (NASDAQ:BIIB) Shares Bought by Integrated Wealth Concepts LLCIntegrated Wealth Concepts LLC grew its stake in Biogen Inc. (NASDAQ:BIIB - Free Report) by 185.1% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 4,479 shares of the biotechnology company's stock afMay 4, 2025 | marketbeat.comBiogen Inc. (NASDAQ:BIIB) Shares Sold by MML Investors Services LLCMML Investors Services LLC decreased its position in shares of Biogen Inc. (NASDAQ:BIIB - Free Report) by 26.9% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 7,515 shares of the biotechnoMay 4, 2025 | marketbeat.comJune 13th Options Now Available For Biogen (BIIB)May 3, 2025 | nasdaq.comSchonfeld Strategic Advisors LLC Raises Stake in Biogen Inc. (NASDAQ:BIIB)Schonfeld Strategic Advisors LLC boosted its holdings in Biogen Inc. (NASDAQ:BIIB - Free Report) by 1,002.7% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 79,516 shares of the biotechnology company's stock after purchasing an additionMay 3, 2025 | marketbeat.comAQR Capital Management LLC Has $81.91 Million Position in Biogen Inc. (NASDAQ:BIIB)AQR Capital Management LLC boosted its position in shares of Biogen Inc. (NASDAQ:BIIB - Free Report) by 982.0% during the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 539,692 shares of the biotechnology company's stock after buyingMay 3, 2025 | marketbeat.comBiogen's results beat estimates on strength in rare disease drugsMay 3, 2025 | msn.comBiogen (BIIB) Maintains Outperform Rating Despite Lowered Price Target | BIIB Stock NewsMay 2, 2025 | gurufocus.comLido Advisors LLC Raises Stock Holdings in Biogen Inc. (NASDAQ:BIIB)Lido Advisors LLC grew its holdings in Biogen Inc. (NASDAQ:BIIB - Free Report) by 2,364.3% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 41,598 shares of the biotechnology company's stock after buyMay 2, 2025 | marketbeat.comDecoding Biogen Inc (BIIB): A Strategic SWOT InsightMay 2, 2025 | gurufocus.comPiper Sandler Cuts Biogen (NASDAQ:BIIB) Price Target to $115.00May 2, 2025 | americanbankingnews.comTruist Financial Cuts Biogen (NASDAQ:BIIB) Price Target to $199.00May 2, 2025 | americanbankingnews.comBiogen Beats Q1 Earnings Expectations As Two Newcomer Drug Sales Spike, Avoids Tariff ImpactMay 1, 2025 | benzinga.comTruist Financial Has Lowered Expectations for Biogen (NASDAQ:BIIB) Stock PriceTruist Financial dropped their price target on shares of Biogen from $210.00 to $199.00 and set a "buy" rating on the stock in a research note on Tuesday.May 1, 2025 | marketbeat.comBiogen Inc. (BIIB) Q1 2025 Earnings Call TranscriptMay 1, 2025 | seekingalpha.comBiogen lowers annual earnings outlook, surpasses Q1 estimatesMay 1, 2025 | investing.comBiogen (NASDAQ:BIIB) Beats Q1 Sales TargetsMay 1, 2025 | msn.comPiper Sandler Issues Pessimistic Forecast for Biogen (NASDAQ:BIIB) Stock PricePiper Sandler decreased their target price on Biogen from $135.00 to $115.00 and set a "neutral" rating on the stock in a research report on Tuesday.May 1, 2025 | marketbeat.com Get Biogen News Delivered to You Automatically Sign up to receive the latest news and ratings for BIIB and its competitors with MarketBeat's FREE daily newsletter. Email Address BIIB Media Mentions By Week BIIB Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BIIB News Sentiment▼0.920.86▲Average Medical News Sentiment BIIB News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BIIB Articles This Week▼3024▲BIIB Articles Average Week Get Biogen News Delivered to You Automatically Sign up to receive the latest news and ratings for BIIB and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Regeneron Pharmaceuticals News Today Alnylam Pharmaceuticals News Today United Therapeutics News Today Incyte News Today BioMarin Pharmaceutical News Today Exelixis News Today Neurocrine Biosciences News Today Exact Sciences News Today Repligen News Today Halozyme Therapeutics News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:BIIB) was last updated on 5/12/2025 by MarketBeat.com Staff From Our PartnersThe one deadline Elon can't afford to miss...For years, Elon Musk made headlines for blowing past deadlines — so often that investors coined a nickname for...Brownstone Research | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredVanishing BenefitsWhat would you do if your next Social Security check simply never arrived? If you called and the line was d...Investors Alley | SponsoredThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredThe Last Time This Happened, Americans Lost BillionsWall Street leaders just held a secret meeting in Las Vegas. What they discussed mirrors 2006 — and the warnin...Banyan Hill Publishing | SponsoredMAY 14: New IPO 350X Bigger Than Amazon IPO?The #1 venture capitalist in America predicts that the biggest IPO in history will take place on Wednesday, Ma...Paradigm Press | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Biogen Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Biogen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy biib Stock Free biib Stock Alerts